Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France

Medigene AG: Medigene Announces Pipeline Expansion into Neoantigens with Programs Targeting Multiple KRAS Mutations and HLAs

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease

Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients

Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities

Mainz Biomed Expands Commercial Footprint into Poland

Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

Destiny Pharma: Board Changes Dr Debra Barker Appointed Interim CEO

ONWARD: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury

Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper